4//SEC Filing
Sakoda Jon 4
Accession 0001209191-18-013937
CIK 0000907654other
Filed
Feb 26, 7:00 PM ET
Accepted
Feb 27, 4:37 PM ET
Size
6.0 KB
Accession
0001209191-18-013937
Insider Transaction Report
Form 4
Sakoda Jon
10% Owner
Transactions
- Sale
Common Stock
2018-02-26$0.50/sh−1,460,209$731,273→ 0 total(indirect: See Note 2)
Footnotes (2)
- [F1]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.475 to $0.625, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (1) to this Form 4.
- [F2]The Reporting Person is a manager of NEA 15 GP, LLC, ("NEA 15 GP") which is the sole general partner of NEA Partners 15, L.P. ("NEA Partners 15"). NEA Partners 15 is the sole general partner of New Enterprise Associates 15, L. P. ("NEA 15"). NEA 15 is the sole member of Growth Equity Opportunities Fund IV, LLC ("GEO IV"), which is the direct beneficial owner of the shares. The Reporting Person disclaims beneficial ownership within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise of such portion of the shares held by GEO IV in which the Reporting Person has no pecuniary interest.
Documents
Issuer
ARCA biopharma, Inc.
CIK 0000907654
Entity typeother
Related Parties
1- filerCIK 0001589961
Filing Metadata
- Form type
- 4
- Filed
- Feb 26, 7:00 PM ET
- Accepted
- Feb 27, 4:37 PM ET
- Size
- 6.0 KB